The company was established in Asia in Singapore. The main department of described VC is located in the Singapore.
For fund there is a match between the location of its establishment and the land of its numerous investments - Singapore. Besides, a startup needs to be aged 2-3 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight One BioMed. We can highlight the next thriving fund investment areas, such as Biotechnology, Medical.
The usual cause for the fund is to invest in rounds with 3 partakers. The meaningful sponsors for the fund in investment in the same round are Seeds Capital, ARCH Venture Partners.
The top activity for fund was in 2019. Deals in the range of 5 - 10 millions dollars are the general things for fund. The fund is constantly included in less than 2 investment rounds annually.
|Cedarview Capital||New York, New York, United States|
|Chandigarh Angels Network||Chandigarh, Chandigarh, India|
|Collate Capital||New York, New York, United States|
|Kuwait Investment Authority||Al Kuwayt, Kuwait|
|Soria Futuro||Las Palmas, Soria, Spain|
|SoundView Ventures||Florida, Miami, United States|
|WndrCo||Beverly Hills, California, United States|
|Yuangu Investment Consulting||China, Deqing, Zhejiang|
|$5M||10 Jul 2019||Central|
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.